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ABSTRACT
Thin wall microcapsules were formed via Layer-by-Layer Self-Assembly of
alternate adsorption of oppositely charged polyelectrolyte on microcores. After the
core dissolution, empty polymeric shells with 20-25 nm thick walls were obtained.
These microcapsules were loaded with Myoglobin, Hemoglobin and Glucose
Oxidase by opening capsule pores at low pH and closing them at higher pH. The
native structure of the enzyme was not affected due to different treatments.
Biocompatible nanoshells were also prepared for encasing DNA. Using the same
Layer-by-Layer Self-Assembly approach nanoparticle were constructed containing
DNA as one o f the layers. The nanoparticles of different architecture were used to
deliver DNA to specific cell lines.
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CHAPTER 1

INTRODUCTION

1.1 Nanotechnology: Nano-organized Thin Films
Nanotechnology has the ability to do things on the atomic and molecular scale.
Nanotechnology is defined on the scale as being between 0.1 and 100 nanometers, a
nanometer being one thousandth of a micron (micrometer), which is itself one-thousandth
of a millimeter. It involves control of materials at scales from the O.lnm up to lOOnm or
sometimes even higher, encompassing both ultra-miniaturization and molecular
manufacturing. The beauty of working at such a scale is that each individual molecule
has its own property, and exploiting such properties is not only becoming fascinating but
also necessary. Nanotechnology is also a multidisciplinary branch where it encompasses
scientists from physics, chemistry, biology and various other specialized fields. The
opportunities for sharing skills and methods, and for joint research, seem endless in
nanotechnology. It is not always easy to define nanotechnology's boundaries. Many
technologies and areas of scientific research, especially in the biological sciences and
biotechnology, are being reclassified as nanotechnology.
In this era, organized macromolecular and nanoparticle films are gaining importance.
Thinfilm science and technology plays an important role in the high-tech industries and
have claimed to be in the environment since last 30 years, but real exploitation of the
1
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novel films and its properties for several multidisciplinary applications has occurred most
recently. Thin films are of great importance to many real-word solutions. The cost of the
material is very less as compared with the corresponding bulk material, yet they have
same functionality when it comes to surface processes. Thus, knowledge and
determination of the nature, functions and new properties of thin films can be used for the
development of new technologies for future applications. By synthesizing specific
functionalities into the polymers, the thin monolayer films can be given specific
functional and performance characteristics useful in a variety of applications. In some
cases, the polymers are better used in thicker films. For these applications, polymer
electrolyte complexes incorporating the same polymer systems are used. Thin films can
be deposited not only on bulk substrates but also onto micro-and nano-templates such as
latex nanoparticles. Features such as the composition (at the surface, interior and
interface of the films), thickness, uniformity, defects, contamination, interface roughness
and bonding, and functionality all can be critically important depending on the film or
coatings application. The mechanical properties of thin films can vary over wide ranges,
depending on their dimensionality, the method of their manufacture, their pre- and postpatterning thermal history, and the constraints imposed by the materials in which they are
embedded. The mechanical properties affect not only their properties and performance,
but also their long-term reliability. Management of thin film is becoming increasingly
important in process and device design for optimum performance and reliability. It is the
understanding of the fundamental behavior of thinfilm properties that facilitates sound
design o f the micro- and nano-systems applications. The application of thin polymer film
materials are conducting polymers, light-emitting polymers, piezoelectric polymer films,
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nonlinear optical materials, nanoscale electronic circuits, protective coatings and
electromagnetic shielding, pharmaceuticals, surface modifications, communication,
optical electronics, catalysis, and many more. Various methods exist for ordered ultrathin
nanofilms that offer various degrees of molecular order and stability, for example, spin
coating, thermal deposition, the Langmuir Blodgett technique, etc. Free standing liquid
crystalline films offer a very ordered structure but are very unstable. The LangmuirBlodgett technique allows the use of planer surfaces only and cannot be applied on large
areas. The disadvantages associated with LB films are that they can be used only on small
and flat surfaces, and the films made with this technique also have some intrinsic defects
at lipid grain borders. Another method that can be applied to surface modification is
monolayer self-assembly, based on thiol or silane compounds. By this method, one can
achieve self-assembly o f 2 to 5 nm thick monolayer on silicon or gold surfaces, but there
is no simple means to assemble thicker films with this approach. Other widely used
methods for the industrial manufacture of thin films are spin coating and thermal
deposition o f macromolecules onto a substrate. Unfortunately, unlike the methods
considered above, these methods do not allow control of the molecular order in the films.
In the last decade the Layer-by-Layer Self Assembly technique (LbL) has received
considerable attention for its simplicity and versatility. In nanotechnology, devices are
fabricated on the sub-micron and nano scale which can be accomplished by manipulating
atoms or molecules as well as overcoming the drawbacks of all previous techniques
discussed. The optimal combination of molecular order and stability of films determines
the practical usefulness of these technologies.
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1.2 Laver-bv-Laver Self-Assembly Technique
Layer-by-Layer

self-assembly

technique

by

alternate

adsorption

of

charged

macromolecules provides a molecular architecture in the direction perpendicular to the
solid substrate [2-9].
This LbL technique can be employed to make ultrathin organized films in a
predetermined architecture with a precision of nanometers. This technique has achieved
considerable attention from the past decade mainly because of its simplicity and
versatility. Layer-by-Layer self-assembly has been employed to make thin multilayers of
polymers [5-15], dyes [16-19], nanoparticles (metallic, semi conducting, magnetic, and
insulating) and clay nanoparticles [20-27], proteins, enzymes [28-32], and other
supramolecular species on virtually any substrate.
Practically all species that have charge can be used for this technique without
modifications, also any o f these species in any order can be adsorbed through this
technique is the greatest advantage. There is no limitation to the number of charged
species that could be used in one single application. The principle of alternate adsorption
was invented for charged colloidal particles and proteins in 1966 in the pioneering work
of Iler [2]. Fromherz proposed the idea to assemble multilayers by alternate adsorption of
charged proteins and linear polyions, but he did not demonstrate experimental results. In
1991, Decher and co-workers introduced a related method for film assembly by means of
alternate adsorption o f linear polycations and polyanions, or bipolar amphiphiles [3-12].
In this method the crucial feature is excessive adsorption (more than neutralization) at
every stage of polycation / polyanion assembly that leads to recharging of the outermost
surface at every step of film orientation.
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1.2.1 L-b-L Self Assembly as Applied
to Flat Surfaces
Fig. 1.1 illustrates the process of LbL self-assembly on flat support. The method provides
the possibility of designing ultrathin multilayer films with a precision better than one
nanometer and with defined molecular composition. The assembly procedure is briefly
shown in figure above. The 2-D application is discussed which was further elaborated on
the 3-D, because the same working principle is used.

©

®

q

a

Polycation
Polyanion

Figure. 1.1 Schematic procedure of electrostatic layer-by-layer self-assembly on
plane 2-dimenional substrates and on 3-dimensional microtemplates
A solid support (e.g., slide) with negative surface charge is incubated in the solution
containing the cationic polyelectrolytes, and a layer of polycation is adsorbed. Since the
adsorption is carried out at a relatively high concentration of polyelectrolytes, a number
o f ionic groups remain exposed at the interface with the solution, and thus the surface
charge is effectively reversed. The reversed surface charge prevents further polyion
adsorption. Solid supports are then rinsed with pure water to remove excess free
polyions. To wash a sample use a solution of pH which keeps polyions ionized. It was
shown [33] that 1 - 2 min intermediate sample water-washing (between subsequent
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adsorption cycles) removes 10 - 15 % of weakly attached material from a resaturated
polyion layer. This fact explains why the step of alternate polyion assembly is precise: It
is not of a big importance that during one cycle we have deposited 90 % or 99 % of a
saturated layer. An intermediate washing will bring them both to the level intrinsic for the
assembly process parameters. The importances of intermediate washing were analyzed
[34] and further dry the sample in a nitrogen stream during alternate assembly. The
surface is then immersed in a solution of anionic polyelectrolytes. Again a layer is
adsorbed, but now the original surface charge (negative) is restored and the surface is
ready for further assembly. These two steps are repeated until a layer of the desired
thickness is obtained. More than two components can be used in the assembly with the
only condition: a proper alternation of positive and negative compounds. The forces
between components and binder layers govern the spontaneous layer-by-layer selfassembly of ultrathin films. These forces are primarily electrostatic and covalent, but they
can also involve hydrogen bonding, hydrophobic, and other types of interactions. That
any of these species in any order can be adsorbed layers is the greatest advantage of selfassembly. The oppositely charged species are held tighter by strong ionic bonds, and they
form long-lasting, uniform, and stable films. Self-assembly is economical and readily
amenable to scaling up for the fabrication of large-area defect-free devices on any kind
and shape of surface. For observation of the assembly growth on the flat substrate the
most commonly used tool is the quartz crystal microbalance [18, 21, 33, 35].
The kinetics of the adsorption process could be delineated by the QCM technique; this
technique is indispensable for establishing proper assembly conditions (a saturation
adsorption time). One does not need to maintain an adsorption time with great precision;
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a minute more or less does not influence the layer thickness if we are at the saturation
region.

1.2.2 L-b-L Self Assembly as Applied
to Colloids
Similarly ordered multilayers can be deposited on colloids (Fig. 1.1), i.e., organic and
inorganic particles. The procedure is similar for 2-D as well as 3-D. The only major
difference is now that the assembly is occurring on the core particles so that the excess of
polyions after deposition will be removed by washing in proper media through
centrifuge. The centrifugation speed is varying according to the size of the core particles,
and after every polyelectrolyte layers deposited three washes will be given to the system
in the appropriate media. Number of core particles can be used to the extent that they are
charged system.
The main idea o f the method consists of the resaturation of polyion adsorption, resulting
in the alternation o f the terminal charge after every subsequent layer deposition. This idea
is general and implies that there is no principle restriction to the choice of
polyelectrolytes as well as core systems. For the successful assembly of nanoparticles or
protein multilayers, the alternation with linear polyion layers is important. Flexible linear
polyions penetrate between nanoparticles and enzymes and act as electrostatic glue. The
self-assembled film contains amorphous polyion interlayer, and this organization heals
defects that arise as a result of the introduction of foreign particles (dust, microbes)
during the process o f film formation. [13, 30]
The thickness may also be controlled by introducing internal layers which indeed will be
providing potential application in the field of drug delivery systems or in diagnostics,
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where the particles can be directed by application of external magnetic fields, [36] and in
turn variation of salt concentration could be very effective for the thickness and bonding
of the polyelectrolyte

[37], The ionic and hydrophobic polyanion polycation

nanoparticles surface charge, created by the adsorption of anions interactions which are
insufficient, can also be immobilized by covalently attaching an anion thiol before
polyelelectrolyte [37]. The polyelectrolyte multilayer film formed through electrostatic
force o f attraction due to its different molecular density can allow selective permeation
and give a cutoff to certain specific species. The advantage posed by the polyelectrolyte
multilayer film is that the porosity of the surface charge can be controlled arbitrarily by
changing the type of polyelectrolyte in the outermost layer, in turn leading to the
application of sensors. [38] Various methods such as adsorption of the polyelectrolytes at
a concentration exceeding saturation amount was combined with removal of the non
bound polyelectrolytes using centrifugation and adsorption of polyelectrolytes with
concentration just sufficient for saturation coverage has been employed for multilayer
growth, resulting in a continuous layer growth. [39] This technique also enables the
arrangement o f the optically active molecules or chemically active functional groups at
molecular level, to produce cooperative electronic and optical properties including electro
luminescence, [40-42] second harmonic generation, [43] and photon induced electron
transfer. [44]

1.3 Basics of Thin Film Adsorption
We are not investigating the chemical kinetics of the films formed using the LbL
technique, but a brief overview is given based on the previous research works. For the
time-dependent control o f adsorption and monitoring of the assembly in situ, the quartz
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crystal microbalance (QCM) method is very well known and suitable [15,34]. The
kinetics o f the adsorption process can be explained by the QCM technique, which is
essential for establishing proper assembly conditions. The multilayer assemblies are
characterized by means o f the QCM technique in two ways:
1. Drying a sample in a nitrogen stream, we measured the resonance frequency shift and
calculated an adsorbed mass by the Sauerbrey equation; this approach is very simple and
most commonly used phenomenon.
2. Monitor the resonator frequency during adsorption onto one side of the resonator,
which was in permanent contact with polyion solution. While performing experiments in
permanent contact with polyion solution, touching the surface of solution with one side of
the resonator while the upper electrode was kept open to the air. The upper contact wire
is insulated from the solution by a silicone paint covering.
Generally, in most publications on polyion assembly, adsorption times of 4 to 15 min are
used as discussed above that, and once saturation region of assembly is reached, time
does not matter. Polyion films swell by 50% before drying, but only 5-10% of the water
remains in polyion films after drying. The high hydration of adsorbed polyions (« 50 wt
%) as compared with the dried film was measured in solution by the light-guiding
attenuation technique [24]. Polyion adsorption occurs in two stages: quick anchoring to a
surface and slow relaxation. To reach a surface charge reversion during linear polyion
adsorption one needs a concentration greater than 10'5 M [45].
The dependence o f polyion layer thickness on concentration is not great: thus, over the
concentration range of 0.1-5 mg/mL, a PSS-PAH pair yielded similar bilayer thickness. A
further decrease in polyion concentration (using 0.01 mg/mL) decreases the layer
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thickness of the adsorbed polyion. An increase in the component concentrations to 20-30
mg/mL may result in nonlinear growth rate with successive adsorption steps, especially if
an intermediate sample rinsing is not long enough [46]. Most of the time the
concentration used for forming films in the cited publications is below 6 mg/ml.
It was proposed that in adsorption from water (at low ionic strength solutions) one deals
with strongly charged polyion adsorption, which forms a well, attached monolayer. In
adsorption from high ionic strength solutions (at salt concentrations of the order 0.1 - 1.0
M) one has partially neutralized polyion chains, which provide adsorption with major
loops and the step o f film growth becomes much greater [13]. Such results are
demonstrated by poly(dimethyldiallylammonium chloride) / poly(styrenesulfonate)
(PDDA/PSS) alternate adsorption from solutions with different ionic strength resulting in
the bilayers growth step variation from 1.6 nm up to 6 nm.
The polycation / polyanion bilayers thickness depends on the charge density of the
polyions. It was shown that more than 10 % of polyion side groups have to be ionized for
a stable reproducible multilayer assembly via alternate electrostatic adsorption [34].
High ionization o f polyions results in a smaller step of film growth ( 1 - 2 nm) and lower
ionization gives a larger growth step ( 3 - 6 nm). It can be reached either by adding salt to
a polyion solution (as discussed above for strong polyelectrolytes, such as PDDA and
PSS), or by varying the pH for weak polyelectrolytes (e.g., polyacrylic acid (PAA) and
poly (allylamine) (PAH), as was analyzed recently by Rubner et al [47].
One other phenomenon generally seen in adsorption of films on the substrate is the
nonlinear growth of the films on substrates [13, 46]. For the first two or three layers,
smaller amount o f polyion are adsorbed than during further assembly, when the film mass
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and thickness increase linearly with the number of adsorption cycles. Tsukruk et al. [46]
explained this effect as an island-type adsorption of the first polyion layers on a weakly
charged support. In the following two or three adsorption cycles these islands spread and
cover the entire surface, and further multilayer growth occurs linearly. If a substrate is
well charged, then the linear growth with successive steps begins earlier. In studying the
possibility of using new compounds in the assembly, a precursor film approach [6, 13,
46] is generally used. Normally repeating two or three alternate adsorptions of PEI and
PSS assembles the precursor films. The outermost layer became negative or positive,
respectively depending on the next layer employed. Some common instruments used for
characterizing the growth of films on the substrates are Surface Contact Angle & UVVis.
1.3.1 Protein Films
The films from proteins have multiple applications and it is very important to preserve
their activity once the proteins are embedded in the layers. To date several proteins have
been used and characterized in films and mostly with positively charged PEI, PAH,
PDDA, or with negatively charged PSS, DNA, or heparin. [14, 23, 48-55].
The proteins are active in the films and thus it attracts the scientists to use them. The pH
of the protein solutions is kept away from the isoelectric point so that the proteins are
sufficiently charged under the experimental conditions. The assembly of 20 different
proteins was successfully achieved as shown in the table (including cytochrome, carbonic
anhydrase, myoglobin, hemoglobin, bacteriorhodopsin, pepsin, peroxidase, alcohol
dehydrogenase, glucoamylase, glucose oxidase, immunoglobulin, catalase, and urease
(Table I) [56]. All the proteins underwent the alternate adsorption with organic polyions
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for unlimited numbers of cycles. The mass increment at each step was quite reproducible.
Proteins immobilized in multilayers with strong polyions such as PSS, PEI, and PDDA
were insoluble in buffer over a pH range between 3 and 10. The assembled proteins are in
most cases not denaturized [29, 32, 57, 58]. Moreover, in some case the L-B-L
immobilization with linear or branched polyions enhanced the enzymatic stability [32],
Table 1.1 Protein - polyion alternate multilayer assembly [56]

Protein

Molecular

Isolect

pH

Weight

ric

used

Charge Alternate
With

Point

Protein

Thickness

Monolayer

of protein

Mass

+polyion

Coverage
(mg/m2)

bilayer
(nm)

Cytochrome c

12400

10.1

4.5

+

PSS'

3.6

2.4+ 1.6

Lysozyme

14000

11

4

+

PSS'

3.5

2.3+ 1.9

Histone f3

15300

11

7

+

PSS'

3.3

2.2 + 2.0

Bacteriorhodopsin

26000

6

9.4

-

PDDA+

7.5

5.0 + 1.0

Pepsin

35000

1

6

-

4.5

3.0+ 0.6

Peroxidase

42000

8.0

4.2

+

PSS'

5.3

3.5

Albumin

68000

4.9

8

PDDA+

23

16.0+1.0

Glucoamylase

95000

4.2

3.9

+

Heparin'

6.8

—

PDDA+,

20.0+ 1.0
30

2.6+ 0.5

4

9.0+ 1.0

PET
Photosynt. RC

100000

5.5

8

PDDA+
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Concanavalin

104000

5

7

Alcohol

141000

5.4

8.5

IgG [72]

150000

6.8

7.5

Glucose oxidase

186000

4.1

6.8

-

PE r

8.6

5.7+ 0.8

PDDA+

12.2

8.5+ 1.0

PSS'

15

10.0

PDDA+

12

8.0

PET

51

34.4+ 0.8

PEE

9.6

6 .4 + 0.8

dehydrogenase

-

6.5
Catalase

240000

5.5

9.2

-

1.4 Formation of Capsules
Several applications of thin films have been mentioned; also the limitless species used for
the LbL assembly renders the opportunity to grow films for the suited applications. The
concept of growing films on the colloidal systems has been elaborated further by
choosing the core systems that can be dissolved under suitable condition without any
damage to the films grown. Thus, much attention has been paid not only to the
elaboration o f microencapsulation technologies but also to designing the polymer/protein
coatings with the pre-determined and controllable physicochemical properties, which can
be of help during dissolution of core without any damages to the wall texture. Preserving
the wall texture is one of very important issue that should be kept during the dissolution
o f the core as once the core is dissolved the walls render their applicability for further
use. Various colloidal templates organic and inorganic such as MF particles (most
commonly used), organic crystals, [59] carbonate particles [60] and biological cells are
used for hollow capsule fabrication.
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Figure. 1.2 LbL Self-Assembly being employed to fabricate hollow capsules
Hollow capsules can be fabricated by dissolving the core at low pH for MF particles and
carbonate particles, organic water-miscible solvents for organic crystals, and the strong
oxidizing agents (NaOCL) for biological cells. The dissolution of core has been intensely
studied on the MF particles, which have been dissolved by 1M NaCL and in some watermiscible solvents DMF or DMSO at lower Ph HCL (Ph<1.2). Today the MF cores are
been replaced by Carbonate cores because of the residues of MF after dissolution in most
cases. The core to be used is based on the application and the polyelectrolyte used; thus,
the dissolution of the core should not have an effect on the wall texture. The hollow
polyelectrolyte capsules with diameter varying from .2 to 10 microns and wall thickness
from few to tens of nanometer are obtained. The size of the template determines the
diameter o f the hollow capsule. The characterization of the hollow polyelectrolyte
microcapsules fabrication can be done with the help of scanning transmission, atomic
force microscopy, and confocal fluorescent microscopy.
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1.4.1 Encapsulation
A new approach to the microencapsulation as an extension of the “layer-by-layer
electrostatic self-assembly” o f different materials, based on alternating adsorption of
oppositely charged polyelectrolytes onto colloid-sized

microparticles, has been put

forward and is now recognized as simple but extremely versatile for designing
nanocomposite multilayered polyelectrolyte film [3, 61-65], The properties o f flat
polyelectrolyte films of microcapsules include the permeability of the walls, which can
be controlled by various possible combinations of different polyelectrolyte pairs, other
charged entities, purposeful chemical modification of starting materials, and unique
alternating packing of positively and negatively charged polyelectrolyte layers. The
release o f the encapsulated core substances into surroundings is achieved either by direct
disruption of polymeric shells in some way, for instance, mechanical, chemical,
biological degradation, the exposure to physical factors like heat, electromagnetic
irradiation o f different wavelength and others or even by subtle management of the
permeability o f microcapsules walls with retaining their overall integrity.

When one

introduces magnetic materials in the shell composition, the release of the encapsulated
particle can be manipulated by applying external magnetic field [25, 66]. After the
formation of the hollow microshell the encapsulation is based on the semipermeable
properties of the polyelectrolyte capsule walls. The permeability o f the wall allows only
low molecular weight such as dyes and ions leaving the higher molecular weight [67].
Researchers are showing a keen interest in switching and controlling capsule
permeability for macromolecules [68]. One possible approach to load capsules with
polymers is to desorb polyelectrolytes from inner layers of empty shells into their
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interior. This technique has several limitations with regard to the polymer species and the
accompanying harsh conditions, such as low pH, oxidizing agents or organic solvents,
which are used for core decomposition [69]. This technique has an appealing application
in the different areas of technology, such as catalysis, cosmetics, medicine,
biotechnology, nutrition, and so on. The properties and structure of the polyelectrolyte
multilayers are sensitive to a variety of physical and chemical conditions of the
surrounding media which might dramatically influence on structure of polyelectrolyte
complexes and result on permeability of the capsules. One of the main influences in the
opening and closing o f the polyelectrolyte walls is governed by change in pH. Upon
variation of the pH, the change in the polyelectrolyte charge induces pore formation of
about 50-200nm or loosening the polyelectrolyte network, which enables the polymer
penetration [70]. The behavior of the polyelectrolyte layers can be made undeformable to
a certain extent by adding lipids. The addition of the lipids to the microcapsule results in
remarkable change in the mechanical properties to the capsule walls. Thus the variation
of the polyelectrolyte can have a great influence on permeability o f molecular species.
Much of encapsulation research today also involves the study of substances called
polymers, chemically manufactured gel-like materials that scientists are using to surround
or encapsulate cells. The properties of the core can be enhanced by pre-charging later on
monitoring the fluorescence to get the information on transport process in the ultrathin
films o f polyelectrolytes emitted during the dissolution of the core, when exposed to
solvent which in turn will influence the capsule porosity for encapsulation of uncharged
low molecular weight organic materials [63, 71].
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Various theoretical models based on several assumptions like permeability of the capsule
wall, charging of the capsule and osmotic balance of the loaded capsule with small ions
and capsule suspended in the bulk solution also help to prove the variation of the pH and
change in the surrounding composition leads to encapsulation [72], also varying the pH
of the surrounding the permeability of the hollow capsule wall can be controlled. The pH
in the interior of the hollow polyelectrolyte capsules and the exterior of the hollow
polyelectrolyte can be kept different as a result of which different solvents can be filled in
the capsules [73]. The loaded material conjugated with the fluorescence dye can be
monitored using confocal microscopy, to check the encapsulation stability. This is one of
the most common methods used today for characterizing encapsulated species. The
quantization of the loaded dye can be made with the help of Spectrofluorometer as the
emission intensity o f the light is directly proportional to the concentration of the analyte.
The encapsulation of the enzymes in the microshell, through the opening and closing of
the pores can be a well known application as a micro and nanoreactor [72]. Taking one
step ahead in the field of loading, researchers have started conjugating the
polyelectrolytes and along with the encapsulating materials. Spectrofluorometer and
Confocal Microscopy are quite famous and most commonly used instruments for
characterizing loading as well as properties of encapsulated materials.
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1.5 Ideology
1.5.1 Protein Loading
Thin wall microcapsules were formed via a layer-by-layer self-assembly by eight-ten
steps of alternate adsorption of oppositely charged poly(styrenesulfonate) and
poly(allylamine) on microcores. After the core dissolution, empty polymeric shells with
20-25 nm thick walls were obtained. These microcapsules were loaded with myoglobin,
hemoglobin and glucose oxidase by opening capsule pores at low pH and closing them at
higher pH.

1.5.2 Nanoparticles for DNA Delivery
Using LbL Technique
The above concept o f assembly on core particles was employed for one of our projects,
Gene Therapy where we are layering core particles of silica with species of interest such
as DNA, Targeting Moieties and many others. Such assembly will help to design the
films on the core particle system, which can further be employed for targeting a specific
site based on the receptor systems. The films on the core particle system will carry
payloads o f required species to be delivered at a specific site. This technique is also been
developed for some bioassays where manufacturers use a fluorescence polystyrene beads
that can be further coupled to antibody, proteins, peptide to target the receptor. Such
technique is already been developed by Luminex Technologies, Austin and is known as
XMAP technologies.
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1.5.3 DNA Encasing
The concept of LbL is used to encapsulate DNA in biocompatible shells. This is a novel
delivery approach where further design of small vectors can be done to help deliver DNA
to the specific targets. This designed experiment helped to construct biocompatible
coatings shells that encased the DNA and protected its native structure.
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CHAPTER 2

MATERIALS & METHODS

2.1 Materials
Several different materials are used in the experiments and some of the major used
materials are given in the table below. The concentration of solution ranges normally
around 2 mg/ml to 5 mg/ml. The materials were used on the bases of the application and
the iso electric point.

Table 2.1 Materials Used
Materials Used
poly(styrenesulfonate) (PSS)
poly(allylamine) hydrochloride (PAH)
Poly(ethylene imine) (PEI)
glucose oxidase

MW g m/mole
70,000
50,000
2,000
186,000

bovine hemoglobin

64,000

myoglobin

17,800

D-Galactosamine Hydrochloride (gala)
chondroitin sulfate (PG)
poly(-L-arginine)

294
45,000-70,000
14,000

20
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sperimidine

254

protamine sulfate

5120

pegfp DNA
DNA calf thymus

4903800
10-15 million

2.1.1 Protein Loading Experiments
Hollow polyelectrolyte capsules were fabricated at pH 6.5, 0.5 NaCl by alternate
adsorption o f four bilayers of sodium poly(styrenesulfonate) (PSS) (Aldrich, MW
70,000) / poly(allylamine) hydrochloride (PAH) (Aldrich, MW 50,000), onto 5-pm
diameter melamine formaldehyde (MF) particles (Microparticles Gmbh, Berlin). For the
multilayer shell formation, ~10n core particles were added to a 2-mL Eppendorf
centrifuge tube followed by the addition of polyions to give shell architectures of the
following sequence: (PSS/PAH)4.6.
For loading, 0.2 mL of capsules and 0.2 ml of proteins with concentration 2 mg/ml were
incubated at pH 6 for 20 min. Then pH of solution was adjusted to pH 10 and remaining
proteins were washed out three times with 2 mL water and centrifugation, so that final pH
= 8. Glucose oxidase, bovine hemoglobin and myoglobin (all from Sigma) were used
without further purification. These proteins were labeled with fluorescein isothiocyanate
(FITC) (Sigma) by incubation with the marker (mass ratio protein / FITC was 30/1) in pH
9 boric buffers for 3 hours at room temperature. Confocal Microscopy was used to
characterize loading.
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2.1.2 Nanoparticles for DNA
Delivery Experiments
Nanoparticles were constructed by using a charged 78 nm silica particles as cores.
(Nissan Chemical, Inc.). Using Layer-by-Layer Self-Assembly technique alternate
charged layers were deposited of polyethylimine, DNA, sugars, and proteins depending
on their charge (Sigma-Aldrich Chemical, Inc). Deposition of each layer was monitored
through sizing and zeta potential with a ZetaPlus (New Haven Instruments, Inc.) Atomic
Force Microscopy was also used for sizing the nanoparticles. DNA, including pEGFP-Cl
and pdsRed-2 were initially obtained from Clontech, Inc. Quantities of DNA were
obtained from transforming specific E. coli with the appropriate plasmid and growing
them. The bacteria were lysed and the DNA isolated through cesium chloride gradients.
All DNA were then concentrated and kept frozen in water. Linear DNA was obtained by
large scale PCR reactions using the above plasmids as templates. After the PCR
reactions, the resulting DNA was isolated using commercial PCR product purification
kits provided by Qiagen, Inc. The DNA after preparation or direct purchase was sent to
Louisiana Tech University for the experiments from University of Texas Medical Branch,
Galveston, Texas. The outer coatings included galactosamine, protamine, and poly
arginine, bovine serum albumin purchased from Sigma-Aldrich, Inc. Lipid coatings were
deposited on DNA coated nanoparticles just before exposure to cells. Lipofectamine 2000
was used to coat the nanoparticles in a method identical for DNA transfections as
directed b y the m anufacture instructions. O nce the non viral vectors w ere prepared they

were send to UTMB for further experiments with cells. Cells were incubated at 37C in
5% C02. Huh-7 and HeLa cell lines were cultured in DMEM supplemented with 10%
FBS (Sigma, Inc.) and Penicillin/Streptomycin (Sigma, Inc.). Cells were transiently
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transfected with Lipofectamine2000 (Invitrogen, Inc.) using the manufacturer’s
instructions. Each experiment was done at least in triplicate.

2.1.3 DNA Encasing Experiment
MnCC>3 particles of 4 fim diameter (from PlasmaChem Gmbh) were taken as template
cores. A 0.5 mg/mL MnCC>3 particle suspension (30 ml) was mixed with 1 mL of 1.5
mg/mL DNA solution (highly-polymerized DNA sodium salt from Calf Thymus, Sigma).
Precipitation of DNA/Sp complex on template particles was made adding dropwise 2 mL
of 1 mg/mL spermidine solution into stirred MnCCVDNA solution. Further alternated
LbL

assembly

of

biocompatible

poly[/3-glucuronic

acid-(l-» 3)-N-acetyl-/3-

galactosamine-6-sulfate-(l^» 4)] (known as chondroitin sulfate, Sigma) (PG) / poly(-Larginine) (PA) shell was carried out with 1 mg/mL PA or PG solutions. After each
deposition step, microparticles were washed out 3 times. A layer-by-layer assembly of
polyelectrolyte layers was monitored by electrophoretic mobility measurements (ZetaPlus
Zeta Potential Analyzer, Brookhaven Instr. Corp). 5 nm assembly steps for PA/PG were
found from parallel PA/PG assembly on QCM electrode (Quartz Crystal Microbalance,
USI-System, Japan). Therefore, a total capsule wall thickness was 40 nm. Further DNA
was also labeled with Rhodamine dye for characterization of loading through confocal
microscope. Circular dichroism was also used to monitor the structure of the
encapsulated DNA.
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2.2 Methods
2.2.1 Capsule Fabrication from
Manganese Carbonate Cores
The fabrication of capsules is as follows:
•

Manganese Carbonate particles with concentration of 10mg/20 mlis taken and
sonicated for 5 minutes.

•

Once sonicated the particles are allowed to sediment, excess of water is thereafter
removed and the particles with 2ml suspension are transferred to a vial.

•

The mixture is centrifuged for 4 min at 3000 rpm.

•

The supernatant is removed, and the particles are suspended in the polyanion solution
untill the 2ml mark (in this case as the substrate is positively charged the polyelectrolyte
used is negatively charged).

•

The suspension is allowed to settle for 15 min.

•

It is centrifuged at 3000 rpm for 4 min.

•

The supernatant is removed and water/buffer is added, centrifuged at 3000 rpm for 4 min.

• Three washes of water/buffer are treated to make sure that no polyanion other than
attached is left in the vial.
• After 3 treatment of water/buffer, the polycation solution is added and the particles are
uniformly suspended with the help of vortex and sonicator. The suspension is allowed to
settle for 15 min.
• Then it is centrifuged for 4 min at 3000 rpm.
• The supernatant is removed, and three washes of the resultant particles with layers of
polyion are washed with water/buffer. This washing removes excess of polyions.
•

Repeat the above steps for desired number of layers.
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After the assembly o f the desired number o f layers the formation of hollow capsules is
the next step in the experiment. The shells treated with the three-water/buffer washes are
kept in the vials after the removal of supernatant.
•

HC1 of pH < 1.1 is added to the vial. As acid is added, the solution becomes clear which
indicates that dissolution is taking place. The cores can also be dissolved by adding
EDTA (EthyleneDiamineTetraAcetic acid dehydrate) solution and keeping it overnight.

•

Due to sensitivity of the hollow capsule wall to low pH conditions, the acidic solution is
removed via centrifugation at 5500 rpm for 15 minutes.

•

Six washes o f water/buffer are treated to remove and makesure that acid is removed
completely.

2.2.2 Capsule Fabrication from
Melamine Formaldehyde Cores
The fabrication o f shells is as follows:
•

Vial of 2 ml capacity is rinsed with de-ionized water and dried using a nitrogen gun.

•

MF particles in the range of 100 to 150 pi are taken in the vial.

•

Tris-buffer solution is added to the vial till 2 ml mark, and the mixture is vortexed or
sonicated for proper suspension.

•

The mixture is centrifuged for 5 min at 6000 rpm.

•

The supernatant is removed and the MF particles are suspendedin the polyanion

solution

till the 2ml mark (in this case as the substrate is positively charged the polyelectrolyte
used is negatively charged ).
•

The suspension is allowed to settle for 15 min.

•

It is centrifuged at 6000 rpm for 5 min.
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•

The supernatant is removed, and tris buffer is added, centrifuged at 6000 rpm for 5 min.

•

Three washes o f tris buffer are treated to make sure that no polyanion other than attached
is left in the vial.

•

After 3 treatment o f tris-buffer, the polycation solution is added and the particles are
uniformly suspended with the help of vortex and sonicator. The suspension is allowed to
settle for 15 min.

•

Then it is centrifuged for 5 min at 6000 rpm.

•

The supernatant is removed and three washes of the resultant particles with layer of
polyion are washed with tris buffer. This washing removes excess of polyions. The
centrifugation specifications are 6000 rpm for 5 min.

•

Repeat the above steps for desired number of layers.
After the assembly o f desired number of layers the formation of hollow capsules is the
next step in the experiment. The shells treated with the three tris buffer washes are kept in
the vials after the removal of supernatant.

•

HC1 o f pH < 1.1 is added to the vial. As acid is added the solution becomes clear which
indicates that dissolution is taking place.

•

Due to sensitivity of the hollow capsule wall to low pH conditions, the acidic solution is
removed via centrifugation at 5000 rpm for 10 minutes.

•

Six washes of tris buffer are treated to remove the acid completely.
Thus hollow microcapsules have been fabricated. After the fabrication of the hollow
shells, the loading o f the shells takes place. Adjusting shell permeability by changing a
solvent (water-alcohol-acetone), ionic strength or pH helps loading phenomenon. For
loading, 0.2 mL o f capsules and 0.2 ml of proteins with concentration 2 mg/ml were
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incubated at pH 6 for 20 min. Then pH of solution was adjusted to pH 10 and remaining
proteins were washed out three times with 2 mL water and centrifugation, so that final pH
=

8.
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CHAPTER 3

INSTRUMENTATION

The most commonly used instruments for characterization of step growth of LbL
assembly on flat surface is the Quartz Crystal Microbalance. Zeta Potential is used for
measuring charge alteration on colloidal systems, it helps to study the deposition of the
alternate polyelectrolyte layers. One of the other commonly used instrument for studying
the bioactivity of the enzymes encapsulated or for performing assays o f the encapsulated
enzyme is UV-Vis. Circular Dichroism was also used for characterization of the native
structure o f the encapsulated materials. It also helps to characterize assembly on flat
surfaces by measuring the absorbance after each layer deposited.

3.1 Quartz Crystal Microbalance
The Quartz Crystal Microbalance (QCM) is a very sensitive mass balance, capable of
sensing mass changes within nanograms. QCM is a mass sensor. The QCM device is
used to study molecular interactions and molecular adsorption to different surfaces, such
as properties o f biomaterials and functionalized surfaces. Applications include proteins,
lipids, polyelectrolyte, polymers, polymer films and cells / bacteria. The QCM technique

28
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determines the mass o f very thin surface-bound layers. A QCM consists of a thin quartz
disc sandwiched between a pair of electrodes. Due to the piezoelectric properties of
quartz, it is possible to excite the crystal to oscillation by applying an AC voltage across
its electrodes. Changes to this resonance are directly proportional to mass changes. If the
film is thin and rigid the decrease in frequency is proportional to the mass of the film. In
this way, the QCM operates as a very sensitive mass balance. The mass of the adhering
layer is calculated by using the Sauerbrey relation:
AT (nm) « -(0.016 ± 0.002) AF (H z).......................................

(2.1)

AM (ng) = - 0.87 AF (H z)...........................................................

(2.2)

where AF is the shift of QCM frequency after each layer is deposited.

Figure 3.1: Picture of QCM instrument

Figure 3.2: SEM picture of a QCM electrode
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3.2 Zeta Potential
The zeta potential is a measure of the magnitude of the repulsion or attraction between
particles. Its measurement brings detailed insight into the dispersion mechanism and is
the key to electrostatic dispersion control. The measurement of zeta potential is an
extremely important parameter. Zeta Potential instrument is used basically for measuring
the charge of solution or colloidal system. Zeta Potential helps to monitor the growth of
film on the colloidal systems. When subjected to an electric field each particle and its
most closely associated ions move through the solution as a unit and the potential at the
boundary between this unit i.e. at the surface of shear between the particle with its ion
atmosphere and the surrounding medium, is known as the zeta potential C,. When a layer
of macromolecules, whether a polyelectrolyte or an uncharged polymer, is adsorbed on
the surface o f the particle, this can alter the zeta potential simply because it shifts the
location o f the shear plane further from the actual surface. Zeta potential is therefore a
function o f the surface charge of the particle, any adsorbed layer at the interface and the
nature and composition of the surrounding medium in which the particle is suspended. It
is usually, but not necessarily, of the same sign as the potential actually at the particle
surface but unlike the surface potential, the zeta potential is readily accessible by
experiment. Moreover, because it reflects the effective charge on the particles and is
therefore related to the electrostatic repulsion between them, zeta potential has proven to
be extremely relevant to the practical study and control of colloidal stability. The
principal of determining zeta potential is very simple. A controlled electric field is
applied via electrodes immersed in the sample suspension and this causes the charged
particles to move towards the electrode o f opposite polarity. Viscous forces acting upon
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the moving particle tend to oppose this motion and equilibrium is rapidly established
between the effects of the electrostatic attraction and the viscous drag. The particles
therefore reach a constant "terminal" velocity. This velocity is dependent upon the
electric field strength or voltage gradient, the dielectric constant and viscosity of the
liquid - all of which are known - and the zeta potential. It is usually expressed as the
particle mobility, which is the velocity under unit field strength. For all practical
purposes, the relationship between mobility, p, and zeta potential, (^, is quite simple.
Helmhoultz-Smoluchowski equation relates this and is given by:

|i = (Ce)/r|
Thus the measured electrophoretic mobility p [E] is converted into the zeta-potential (z
[mV]) by using the Helmholtz-Smoluchowski relation. The value of the zeta-potential
indicates the surface charge of a particle. High absolute zeta-potentials indicate stable
colloidal systems. The alternate value of zeta-potential is indicative of the successful
recharging of the colloidal surface in layer-by-layer assembly.

Figure 3.3: Picture of Zeta Potential instrument
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3.3 Circular Dichroism
Circular Dichroism spectroscopy is particularly good for:
•

Determining whether a protein is folded and if so characterizing its secondary
structure, tertiary structure and the structural family to which it belongs

•

Comparing the structures of a protein obtained from different sources (eg. species,
or expression systems) or comparing structures for different mutants of the same
proteins

•

Demonstrating comparability of solution conformation after changes in
manufacturing processes of formulation

•

Studying the conformational stability of a protein under stress-thermal stability,
pH stability, and stability to denaturants and how this stability is altered by buffer
composition or addition o f stabilizers

•

Determining whether the protein-protein, protein-polymer interaction alter the
conformation of proteins

Circular Dichroism spectroscopy is a type of absorption spectroscopy that can provide
information on the structures of many types of biological macromolecules. Circular
Dichroism is the difference between the absorption of left-handed and right-handed
circularly polarized light and is measured as a function of wavelength. Molecules
produce a circular dichroism spectrum because they absorb left-handed and right-handed
polarized light to different extent and thus are considered to be optically active.
Biologically macromolecules such as proteins and DNA are composed of optically active
elements, and because they can adopt different three -dimensional structures each type of
molecules produces distinct circular dichroism spectra. Different types of protein
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secondary structures such as helices, sheets, turns, and coils give rise to different circular
dichroism spectra. Due to the helical structure of double-stranded DNA, its circular
dichroism (CD) spectrum has a strong signal in 230-350 nm range. This characterization
helps to determine the structure of the molecule after encapsulation or exposing to hostile
environment.

3.4 Atomic Force Microscopy
The Atomic Force Microscopy is being used to solve processing and materials problems
in a wide range of technologies. The materials, which can be investigated, include thin
and thin film coatings, ceramics, composites, glasses, polymers and many more. By using
AFM one can image surface in atomic resolution and also measure force at atomic level.
The atomic force microscope is one of about two dozen types of scanned-proximity probe
microscopes. All these microscopes work by measuring a local property such as height,
optical absorption, or magnetism with a probe or "tip" placed very close to the sample.
The basic objective o f the operation of the AFM is to measure the forces (at the atomic
level) between a sharp probing tip (which is attached to a cantilever spring) and a sample
surface. The small probe-sample separation (on the order of the instrument's resolution)
makes it possible to take measurements over a small area. AFM operates by measuring
attractive or repulsive forces between a tip and the sample. In its repulsive "contact"
mode, the instrument lightly touches a tip of "cantilever" to the sample. As a raster-scan
drags the tip over the sample, some sort of detection apparatus measures the vertical
deflection o f the cantilever, which indicates the local sample height. Thus, in contact
mode the AFM measures repulsion forces between the tip and sample. To acquire an
image, the microscope raster-scans the probe over the sample while measuring the local
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property in question. The resulting image resembles an image on a television screen in
that both consist o f many rows or lines of information placed one above the other. The
ability of AFM to image at atomic resolution, combined with its ability to image a wide
variety of samples under a wide variety of conditions, has created a great deal of interest
in applying it to the study of biological structures. Images have appeared in the literature
showing DNA, single proteins, and living cells. This characterization helps us to
understand the size dimension of the nanoparticles for DNA delivery as well as allows us
to see how a hollow capsule looks like.

Figure 3.4: Picture of Atomic Force Microscopy Instrument

3.5 Confocal Laser Scanning Microscope
Confocal Laser Scanning Microscopy (CLSM) offers observation of thin optical sections
in thick, intact specimens. In conventional fluorescence microscopy, out-of-focus
fluorescence, evoked by the excitation light, tends to overwhelm details in the actual
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image plane. In CLSM a laser light beam is expanded to make optimal use of the optics
in the objective. Through a x-y deflection mechanism this beam is turned into a scanning
beam, focused to a small spot by an objective lens onto a fluorescent specimen. The
mixture of reflected light and emitted fluorescent light is captured by the same objective
and (after conversion into a static beam by the x-y scanner device) is focused onto a
photodetector (photomultiplier) via a dichroic mirror (beam splitter). The reflected light
is deviated by the dichroic mirror while the emitted fluorescent light passes through in the
direction of the photomultiplier. A confocal aperture (pinhole) is placed in front of the
photodetector, such that the fluorescent light (not the reflected light!) from points on the
specimen that are not within the focal plane (the so called out-of-focus light) where the
laser beam was focused will be largely obstructed by the pinhole. In this way, out-offocus information (both above and below the focal plane) is greatly reduced. This
becomes especially important when dealing with thick specimens. The spot that is
focussed on the center of the pinhole is often referred to as the "confocal spot." CLSM is
a powerful tool for three-dimensional (3D) analysis of fluorescently labelled specimens,.
This instrument is a very important for characterizing whereby one can conjugate
fluorescent labelled molecules to proteins, enzymes as well as nanoparticles that helps to
determine the amount of labelled proteins that is entrapped in the capsules and well as in
walls of the capsules. This is one of the most common techniques used to understand the
loading process in capsules fabricated using Layer-by-Layer tool. This instrument was
also used for characterizing the protein expression detection for DNA delivery projects.
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Figure 3.5: Picture of Confocal Laser Scanning Microscope Instrument

3.6 UV-vis Spectroscopy
Many compounds absorb ultraviolet (UV) or visible (Vis) light. When a beam of light of
a particular wavelength is passed through the solution absorption occurs. Thus if all the
light passes through a solution without any absorption, then absorbance is zero, and the
percent transmittance is 100%. If all the light is absorbed then percent transmittance is
zero. This absorption is given by Beer-Lambert Law:

A = ebc
Where A is absorbance
e is molar absorptivity with units of L/m ol. cm
b is path length of the sample in cm, that is the path length of cuvette in which
sample is contained
c is the concentration of the compound in solution and is given by mol/L
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Hence, absorbance is proportional to the concentration of the solution. Thus UV-Vis
spectroscopy is used as one of the characterization of the LbL film on the quartz slide.
Therefore, as the films are developing, the absorption goes on increasing, which is an
indication of film growth. This instrument was also employed for assay characterization.
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CHAPTER 4

PROTEIN ENCAPSULATION IN THIN
WALL POLYION MICROSHELLS

4.1 Introduction
A thinfilm assembly by means of alternate adsorption of oppositely charged linear
polyions was introduced in the mid-nineties by Decher etal [3]. The basis of this method
involves resaturation of polyion adsorption, resulting in the reversal of the terminal
surface charge o f the film after deposition of each layer. The method provides the
possibility o f designing ultrathin multilayer films with a precision o f one nanometer and
with defined molecular composition. The assembly process elaborated for planar solid
supports was adapted for microtemplates (colloidal particles with sizes of 0.2 to 5
microns, e.g. latex spheres, microcrystals, biological cells and other colloids) [61, 62, 66,
68, 74-83]. In this process, a liner polycation solution is added to the suspension of
colloid particles, and after adsorption saturation, particles are separated from free
polycations in solution. Then, a linear polyanion layer is deposited (Fig. 4.1). In the sam e

manner, one can deposit any number of polyion layers on the core. A typical polycation /
polyanion bilayer thickness in such a process is 4-5 nm [68]. After the shells are formed,
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one can dissolve the core particles to obtain empty capsules with a wall thickness tuned
in range from 10 to 50 nm and with needed composition [61, 62, 66, 68, 75-77]. A shell
material and layer number can vary the permeability properties of polyion capsules. The
wall permeability for macromolecules depends on pH: at low pH poly(styrenesulfonate)/
poly(allylamine) capsule walls were opened, and at pH higher than 7.5 they were closed
[68, 77-79] which probably is related to the pore formation due to misbalance of charges
in the polycation / polyanion multilayer complex [70]. Molecules with weight less than ca
4,000 can penetrate through walls also in their closed state [77],
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Figure 4.1: a-b Scheme of the capsule assembly and AFM image of dry 5-pm
diameter (PSS/PAH )4 capsule
By varying the pH o f the capsule suspension in the presence of the proteins, one can open
and close their wall pores and to perform an encapsulation. Therefore, one can encase
enzymes inside the polyion capsules with nano-organized walls where they will be
protected against high molecular weight inhibitors (such as proteases). Low molecular
weight substrates (such as glucose) can easily penetrate inside the capsule by diffusion.
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Construction of such enzymatic microreactors was recently demonstrated for urease, a chymotrypsin and peroxidase [79, 80].
In this work, as a part of our efforts to create a new protein microcarrier, we demonstrate
polyion capsule loading with glucose oxidase, hemoglobin and myoglobin and analyze
some features o f the loading process. In particular, a concentration of proteins inside the
capsules, a ratio between the mass of the encapsulated proteins and the mass of the
polymer shell, the mass of proteins which are bound to polycation/polyanion walls, and
an enzymatic activity of encased glucose oxidase were studied.

4.2 Experimental Procedure
4.2.1 Microencapsulation
We encapsulated proteins in microshells assembled via layer-by-layer assembly of linear
polycations and polyanions on a 5-|o.m diameter template. Hollow polyelectrolyte
capsules were fabricated at pH 6.5, 0.5 NaCl by alternate adsorption of four bilayers of
sodium poly(styrenesulfonate) (PSS) (Aldrich, MW 70,000) / poly(allylamine)
hydrochloride

(PAH)

(Aldrich,

MW

50,000),

onto

5-pm

diameter melamine

formaldehyde (MF) particles (Microparticles Gmbh, Berlin). For the multilayer shell
formation, -1 0 11 core particles were added to a 2-mL Eppendorf centrifuge tube followed
by the addition of polyions to give shell architectures of the following sequence:
(PSS/PAH)4.6. After addition of the polyions, 15 min were allowed to elapse so that
saturation adsorption of the polyions on the colloid particles was reached. The coated
latex spheres were then centrifuged at 300 g, and the supernatant containing the
unadsorbed species were removed. This procedure was repeated three times after the
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adsorption step to avoid admixing of the sequentially deposited components. To dissolve
melamine formaldehyde cores, we decreased pH to 1.
The capsules prepared via alternating adsorption of oppositely charged poly(allylamine
hydrochloride) and poly(styrenesulfonate) with composition (PSS/PAH)4 .6 have been
shown to be permeable to macromolecules at pH values below 6 and closed at pH above
7.5 (Fig. 4.2).
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Figure 4.2: Confocal cross-sectional images of (PSS/PAH)4 capsules with open wall
pores (at low pH) and closed pores (at high pH). FITC labeled dextran (MW 70,000)
was added to the solvent as fluorescent indicator
For loading, 0.2 mL of capsules and 0.2 ml of proteins with concentration 2 mg/ml were
incubated at pH 6 for 20 min. Then the pH of solution was adjusted to pH 10 and
remaining proteins were washed out three times with 2 mL water and centrifugation, so
that final pH = 8.
Glucose oxidase, bovine hemoglobin and myoglobin (all from Sigma) were used without
further purification. These proteins were labeled with fluorescein isothiocyanate (FITC)
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(Sigma) by incubation with the marker (mass ratio protein / FITC was 30/1) in pH 9 boric
buffer for 3 hours at room temperature and further purification with chromatography on
G-50 Sephadex (Sigma) as a carrier following a procedure described in [79].

4.3 Instruments
The Confocal microscope Leica TCS SP, equipped with a 100x/1.4-0.7 oil immersion
objective was used for visualization of the microshell cross-sections. The investigated
capsule suspension was placed between a glass slide and a cover slip glued at the edges.
Excitation wavelength 488 nm was chosen according to fluorescein labels. The
fluorescence intensities o f the scanned capsules were measured and processed with Leica
TCS software. The scanning force microscope Nanoscope III Multimode SFM (Digital
Instrument Inc., Santa Barbara, CA) was used in tapping mode and images were
processed with Nanoscope software. Samples were prepared by applying a drop of
capsule suspension onto a freshly cleaved mica support. Eppendorf centrifuge was used
for a capsule preparation. UV-vis spectra measurements were performed on HP-Agilent
8453 spectrophotometer (USA).

4.4 Glucose Oxidase Activity Assay
To measure the activity of the glucose oxidase (GOx) multilayers, we used an assay
recommended by Sigma: 2.4 mL of 0.21 mM o-Dianisidine solution in 50 mM sodium
acetate buffer (pH 5.1), 0.5 mL of 10 % (w/v) P-d-glucose solution and 0.1 mL of a
peroxidase solution (containing 60 units mL'1) were mixed in a cuvette and airequilibrated until the absorbance at 500 nm was constant. GOx or capsules were added,
and absorbance data were recorded continuously for 4 min, starting immediately after
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mixing. For each experiment, the same enzyme concentration was added to this test
solution. The assay is based on production of H2 O2 in the enzyme-substrate reaction; the
peroxide is in turn consumed by peroxidase to result in catalytic oxidation of dianisidine,
resulting in dark red coloration (maximum absorbance at 500 nm).

4.5 Results and Discussion
4.5.1 Glucose Oxidase and Hemoglobin
Encapsulation
Figure 4.3-4.4 shows confocal and AFM images of 5-pm diameter (PSS/PAH)4 capsules
loaded with FITC labeled hemoglobin and GOx. In both confocal pictures, capsule crosssectional images indicate the presence of the labeled protein inside the capsules and the
absence of labeled proteins outside. The walls of the capsules are brighter than the
interior, showing that the larger density of labeled proteins is in the polyion walls. Next
to the images we presented brightness curves indicating the amount of the protein inside
and outside of the capsule. Figure 3b shows a typical AFM image of the dried loaded
capsules. One can see that during drying, the capsule collapsed and some material from
inside was seen next to the defective part of the capsule.
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G O x e n c a p su la te d
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Figure 4.3: FITC-GOx loaded capsules: a- confocal cross-sectional image in solution
at pH 8 and the fluorescent intensity profile, b - AFM tipping mode image of the
dry broken capsule on mica surface
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Figure 4.4: FITC-hemoglobin loaded capsule: Confocal cross-sectional image and
fluorescent intensity profile of the capsule
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Let us estimate the capsule dimensions: for 2.5-jim radius and 20-nm thick (PSS/PAH) 4
shell [76] we have a total capsule volume of Vc = 65-1 O'12 cm3, while the volume of the
polyion shell only: Vs = 9.4-10'13 cm3. Taking hydrated polyion density as ca 1.05 g/cm3,
one has the shell mass of Ms = 9.8-10'13g.
How much proteins are encased into the capsule? For loading, we mixed an equal amount
of the shell dispersion and 2 mg/mL protein solution. Concentration of loaded capsules
was calculated by a direct count of dried capsules suspension done from the optical
microscopy; for myoglobin loaded capsules it was N - 10.5 106 cm'3, for hemoglobin
capsules it was N = 8.5 106 cm'3, and for glucose oxidase n = 3 106 cm'3.
Concentration of proteins in the capsules was determined with Loury method [84] and
was found C = 0.02 mg/mL for myoglobin and hemoglobin and C = 0.007 mg/mL for
GOx. Dividing these values on the number of capsules in one milliliter, one obtains the
protein loading in one capsule MMb = 0.19 10'11 g, MHb = 0.24 10'11 g, M gox = 0-23 10'11
g. The concentrations of proteins in the capsules will be C\ib = 29 mg/mL, Cnb = 36
mg/mL, and Cgox = 35 mg/mL,
Comparing this weight with the weight of empty dry shell (9.8-10 '13 g), one finds that
shell mass consists o f 30 % of the dry mass of loaded capsule and proteins give ca 70 %
of the loaded capsules mass.
It is remarkable that concentration of loaded proteins (29-36 mg/mL) is higher than
concentration in protein solutions used for the loading (ca 1 mg/mL). Probably, some
unclear mechanism exists which “pumps-in” proteins inside the shells.
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4.5.2 Hypothesis:
•

The shell wall have negative charge at the inner surface (first layer was
poly(styrenesulfonate)) and positive outermost layer (poly(allylamine). This
asymmetric wall can provide a driving force for increased protein concentration
inside the capsule as compared with concentration at the loading solution.

•

Another reason may be in protein/polyion complex formation in the capsule
multilayer wall. Later, we have shown with Myoglobin loading that this
mechanism could be responsible for ca 20 % from the total loaded proteins.

•

It was earlier reported that while using MF as a template for fabrication of hollow
capsules there are some MF oligomer remaining in the capsules. This oligomer is
positively charged and hence during the loading of proteins they form complexes
and higher concentration of proteins is seen inside the capsules.

•

When Ficks law of diffusion is applied to molecular diffusion across charged
membrane, one can draw an analog stating that the rate of diffusion of molecules
across charged capsule walls is directly proportional to the potential barrier across
the wall and inversely proportional to the thickness of the capsule wall. The
potential barrier across walls fabricated for 4 bilayers of PSS/PAH is +10 mV
which means that it aids in the entry of proteins inside the capsules. In addition
MF(oligomer)/PSS complex which has a high +ve charge along with +ve
potential barrier creates electrostatic force which attracts proteins inside the
capsule but also slows down or completely hinders the diffusion of proteins out of
the capsules.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47

Proteins encased in the capsules preserved their bioactivity as it was shown earlier for
urease, a-chymotrypsin and peroxidase [79, 80], and it will be demonstrated below for
glucose oxidase. GOx loaded in capsules, initially shows 60 % of activity as compared
with the enzyme solution, and it dropped to 35 % after 15 days, to 10 % after 70 days,
and to 6 % after 85 days after encapsulation (capsules were kept at 25° C first two days
and then at 5° C) (Fig. 4.5). All activity checks were performed with FITC-labeled GOx.
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Figure 4.5: FITC-GOx bioactivity (proportional to the absorbance increment) for
the equal enzyme amount (0.007 mg/mL) free in solution (diamonds) and in the
shells 15 days after encapsulation (squares), 70 and 85 days after encapsulation (red
and blue)
It is of interest to compare our data with glucose oxidase bioactivity in solution and
assembled in the polyion films [85]. GOx enzymatic activity in the film assembled by
alternation with polycation was 80 % as compared with the enzyme solution, and it
dropped to 22 % after 28 days keeping at 25 C. These results are close to our results, but
in the capsule GOx activity produced by the enzymes bound to the walls and the enzymes
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encased inside the capsules, and the storage properties of the GOx in these two states may
be different.
One of the purposes o f this study was to conduct encapsulation in a way that does not
affect the native structure o f proteins. It is important for enzymes to keep their activity
and for hemoglobin to maintain its oxygen-binding ability. It was established [86] that the
spectrum of hemoglobin is very sensitive to the changes of hem conformation and the
maximum adsorption at 409 nm (Soret band) shifts by more than 2 nm if any changes
occur. The spectrum o f capsules with FITC-labeled hemoglobin encapsulated (Fig. 4.6)
was recorded for verification of possible changes that could occur during loading or due
to the contact of the protein with the capsule wall. No shift of Soret band was registered;
only the second peak corresponding to the fluorescein marker appeared at 496 nm.
Therefore, hemoglobin in the capsules preserved its native conformation. Though
hemoglobin was encapsulated in the capsules there was no observation of scattering in
the spectrum because the polymers have absorbance below 300nm and the spectra
collected is above 300nm.
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Figure 4.6: UV-spectrum of encapsulated FITC-hemoglobin, pH 7.5
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4.5.3 Myoglobin Encapsulation
Myoglobin encapsulation was performed in a similar manner into (PSS/PAH ) 4 capsules
(Fig. 4.7), and loading of (0.19 ± 0.05) 10"11 g per capsule was found. This loading is less
than loading of glucose oxidase and hemoglobin in spite the initial concentrations of
these proteins used for the loading were similar. Probably, a smaller molecular weight
and dimensions o f myoglobin (as compared with hemoglobin and GOx, correspondingly,
17,800; 64,000 and 186,000) result in its partial leakage from the capsules.
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Figure 4.7: Confocal cross-sectional image of FITC-Mb loaded capsules and
fluorescent intensity profile of the capsule

Above, we gave a total amount of myoglobin encased inside the capsule. Further we will
estimate an amount o f the protein bound to the capsule walls only. For this we prepared
the capsules with open (broken) walls (i.e., capsules unable to keep Mb inside, as it was
evident from confocal images of labeled Mb admixed with the empty shells). Figure. 4.8
shows these two routs o f the myoglobin encapsulation.
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Figure 4.8: Scheme of the two routes of myoglobin encapsulations based on pH
variation for unbroken (upper route) and broken (lower route) shells

4.5.4 Myoglobin Complexation with
Open (Broken) Shells
Turning attention to discuss myoglobin loading to the walls of the open (broken) shells,
these shells were obtained by PSS/PAH assembly on the special MF cores with higher
degree o f polymerization. Such cores, during dissolution at low pH, broke the capsule
walls that could be proved by CLSM experiments with FITC-labeled myoglobin.
Loading was performed by adding myoglobin to the capsule dispersion. The protein
concentration was 0.7, 1.4, 3.4 and 6.8 mg/mL. Loading was performed both at pH 5 and
pH 8 to broken capsules (with washing after the loading). The resulting concentration of
myoglobin bound to the shells was determined from Soret band maximum (409 nm, hem
absorbance) at pH 8 when capsules were washed out from myoglobin solution.
Table 4.1 and Figure. 4.9 show that the mass of myoglobin bound to one broken capsule
depends on the shell’s outermost charge and initial protein concentration. We found that
binding at pH 5 was more effective than at pH 8. Besides, at pH 5, Mb binding to broken
capsules with anionic (PSS) outermost was twice as efficient as for using the capsules
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with cationic (PAH) exteriors. The isoelectric point of myoglobin is at pKa 6.8, and at pH
5 myoglobin has charge +10 [58]. This phenomenon could explain larger myoglobin
adsorption in capsules with anionic outermost layers. Myoglobin constituted ca 50 % of
the mass of the capsule with (PSS/PAH)5 +PSS wall immersed into more than 3 mg/mL
of myoglobin solution (Table 4.1).
Table 4.1: Myoglobin loading in (PSS/PAH)s + PSS broken shells, pH 5 (with
washing after loading at pH 8)
Mb part from total mass of
Protein

concentration Protein per one

capsule
capsule

mg/mL

x lO’12 g

0.7

.33

25%

1.4

.43

31 %

3.4

.96

49%

6.8

1.06

52%
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Figure 4.9: Loading of myoglobin in the shell wall depending on the protein
concentration in the initial solution and on the outermost of the capsules, loading at
pH 5, washing at pH 8
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Let us analyze an amount of encased and bound myoglobin for initial loading
concentration of 1 mg/mL. An amount of myoglobin bound to the capsule walls is
0.38-1 O'12 g as established from its adsorption to broken capsules, which is ca 20 % of
Mb encased in intact unbroken shells (0.19T0'11 g per capsule).
An Atomic Force Microscopy (AFM) analysis of the loaded shells has shown regularly
distributed mottled appearance with average diameter of (50 ± 20) nm (Figure. 4.10).
These “blisters” were not found on empty unloaded shells. We assume they could be
stoichiometric complexes formed by cationic myoglobin and anionic PSS. We have to
mention that the capsule wall assembly was performed from polyion solutions in 0.5 M
NaCl; therefore, not all ionized groups of PSS and PAH “locked” one with another, and
remaining charged groups can react with oppositely charged regions on the Mb globule
surface. Formation of similar 100-nm diameter complexes for albumin/polycations
coacervates was found by Kabanov [87]. This new formation is an indication of Mb
bound on the capsule walls. A diameter of the “blisters” is close to the capsule wall
thickness (30 nm for six bilayers), which indicates that they penetrate the walls. There are
ca 230 “blisters” per 1 pm and they occupy ca 40 % of the capsule surface showing twodimensional close-packed picture. The capsule surface is 78.5 pm2, therefore, we have ca
18,000 “blisters” per capsule. Such blisters were never detected for (PSS/PAH)-capsules,
but they are rather similar to “grains” of (90 ± 10) nm diameter found for (PSS /
poly(dimethyldiallyl ammonium chloride))5 capsules [88]. Authors of [88] also proposed
that the grains are specific complexes of several polyion molecules.
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Figure 4.10: AFM capsule image of open-wall capsule with 3 mg/mL myoglobin
loading concentration. (Image taken at Max Plank Institute in collaboration with
Dr Dmitry Schukin)

4.6 Conclusions
We presented results on loading myoglobin, hemoglobin and glucose oxidase into
polyion microcapsules. Earlier, it was reported about loading to the similar capsules of
a-chymotrypsin (MW 25,000) and urease (MW 34,000) [11-12], Analyzing the process
of loading these proteins to the (PSS/PAH)4.6 polyion capsules, we can conclude:
By opening capsule pores at low pH and closing them at high pH, one can load inside
proteins with concentrations much higher than the concentration of the initial protein
solution. At the concentration of loading proteins of 1 mg/mL, they result in ca 30
mg/mL protein concentration in the globules and proteins consist 70 % of total mass of
the globule, and mass of the polymer shell is 30 %. The loading features were similar for
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these proteins with mass range froml 7,800 to 186,000. Biological activity of glucose
oxidase was 60 % as compared with the activity of free enzyme in solution, and dropped
to 20 % o f the initial activity after two months storage at 5° C.
Additionally to the proteins encased inside the capsules, there are proteins bound to the
capsule walls. For myoglobin, the amount of such bound proteins increases with
concentration of myoglobin in solution used for the loading and reached a saturation at C
= 3.5 mg/mL. The mass of this largest amount of myoglobin bound to the capsule wall
approximately equals to the half of capsule mass. Therefore, we have the following
approximate composition for 5-pm diameter (PSS/PAH ) 4 shell loaded with 1 mg/mL
myoglobin solution: 55 wt % of the mass are encased proteins + 15 wt % bound proteins
+ 30 wt % the shell mass, and total concentration of myoglobin in the capsule is 29
mg/mL. This is only a general estimation and it can be changed with varying a
concentration of the proteins used for the encapsulation.
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CHAPTER 5

NANOPARTICLES FOR DNA DELIVERY USING
LBL TECHNIQUE

Transfecting foreign DNA into cell culture and in vivo is under consideration. Layerby-layer constructed nanoparticles were designed for safe and targeted delivery of
foreign genes. The nanoparticles were constructed using a 78 nm silica core particle,
on which deposition of DNA, poly (ethyleneimine), and target assisting molecules
were assembled in nano-organized manner. The targeting moieties included N-acetyld-galactosamine, poly(arginine), Protamine, and lipids. The targeted cell type is
hepatocyte, they have asialoglycoprotein receptors on outer surface. These receptors
contain the carbohydrate recognition domains that can endocytose large particles when
bound and have also shown affinity towards galactosyl residues. By coating the outer
layer with lipid, the nanoparticle can enter the cell through permeating the cell
membrane. We found the size of nanoparticles is more critical for lipid coated than for
sugar coated particles when delivered to liver cells. Nanoparticles ranging up to 300
nm are permeable to liver derived cells. We report the development of a layer-by-layer
method for creating nanoparticle based gene delivery vectors. The layer-by-layer
nature of particle construction allows greater flexibility and fine control of not only
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what is delivered to the cell, but also it can be designed in the later stages eventually,
how these components are released into the cell.

5.1 Introduction
Layer-by-Layer (LbL) self-assembly technique has spread its applications in various
aspects of sciences since its adaptation. This technique has come forward since its
early applications in nineties with its simplicity of polyion adsorption. [3, 6, 21, 29].
With the span o f time since its implication this alternate adsorption can be used for
several species such as charged polymers, proteins, lipid bilayer, biospecific
complexes, bola-ampiphiles, conductive polymers and organic dyes [89-93] Thin films
obtained are in the range o f few to hundreds of nanometer with a precision of one
nanometer and in a nanoorganized manner. With its varied choice of biocompatible
materials the microshells have found its application in various medical fields among
which study of drug release properties, delivering loads to specific sites and forming
biosensor are most common. [94-96]
Various approaches are emerging towards gene therapy. The basic gene therapy
should have:
•

Gene delivery system,

•

A gene that encodes the proteins

•

The plasmid that controls the functioning of the gene within the cell [97].

Biodegradable polymers have been used from drug delivery to tissue engineering and
have even advanced to the gene therapy, which allows us its use for LbL construction
of nanoparticles to attain a vector component for gene expression. [98,99] The most
common and also effective method for gene delivery is to form complexes with DNA
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using poly(ethyleneimine) [100,101], poly(lysine) [100, 102], chitosin [100], lipids
and many other biodegradable polymers [103] which can achieve gene medicine.
Some other approaches invovles naked DNA, “gene gun”, chaser injection and
electroporation [100, 101].
Existing gene delivery systems have a variety of limitations:
•

These systems are designed to eliminate an infection by transferring a
therapeutic gene to host cells, however, they have been largely unsuccessful
since only low doses of genetic material can reach the target specific cell types
that are infected

•

Increased side effects are also due to non specific targeting of non infected
cells with genes

•

Host cells reaction to the carrier molecules used associated with their gene
delivery

As such there is currently a need for a gene delivery system that has minimal side
effects but high potency and efficiency. One such system could be that of the Layerby-Layer self assembled nanoparticles coated with targeting biomolecules. A novel
concept of LbL also allows modifying the polymer surface by electrostatically
attaching specific targeting molecules that can be organized with precisions of
nanometer for gene expression. A specific cell line can be targeted with this vector in
a cell population. Thus, nonviral gene delivery systems can be designed with idealized
structural and chemical properties that can enter through the receptor in the cells. The
receptor on the targeted cell asialoglycoprotein (ASGP) receptor has reported to show
high affinity for galactosyl residue. In our approach to achieve transfection we chose
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targeting moieties such as N-acetyl-d-galactosamine (gala), [104] poly-l-arginine
(parg) [105] and protamine sulphate [106,107] as the outer coating of the nanoparticle
vector. The targeting moieties on the polymer have been used as promoters for
delivery and gene expression. [104-107]. Bionanoparticle complexes, while still in
their infancy as a new bionanotechnology, hold great promise for more sophisticated
targeting and controlling drug/gene delivery to specific cells. Delivery of the
drug/gene to a cell surface by conventional targeting does not insure that it is delivered
to the site of required action within the cell. The nanosystems can contain intracellular
targeting molecules that re-direct the nanomedicinal system to the correct intracellular
location for specific molecular and biochemical actions. For example, the interior of a
10-micron diameter cell is much higher than the volume of an individual 100 nm
diameter nanoparticle. Prior studies using confocal microscopy have been used to
verify that the drug/gene is targeted to the correct location within the single cells.

5.2 Ideology/Strategy

Figure 5.1: Targeting nanoparticle Ideology/Strategy
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The strategy for the gene delivery and gene expression is on the basis of endocytosis
o f the nanoparticles through the asialoglycoprotein receptor on the Huh-7 cell lines
and disassembling of nanoparticles within the cells. Targeting this receptor for the
entry to the cells would be possible by different outer layer moieties that can have
affinity towards the receptors. LbL method allows architecture design of nanoparticles
with needed configuration o f different species in the shells. The mechanism can be
idealized for the nanoparticles if they were taken up by the receptor rather then just
penetrating in the cell lines.

Lipid-coated particles have reported to work with

mechanism as well as without mechanism. As the nanoparticles are uptaken by the
cells, the cell wall forms a membrane bound vesicle around the targeting vector.
Following the endocytosis of the nanoparticles the pH drops about 3 to 4 in the
membrane bound vesicle, this helps the layer by layer assembled nanoparticles to take
advantage of the environment to disassemble thus leaving the plasmid DNA free. For
gene expression the synthesis of RNA by RNA polymerases using a DNA template
(transcription) should take place where further RNA translates to the protein
expression. For gene therapy the sequence of events occurring in line would be the
task o f our targeting nanoparticle. Complex multilayered nanoparticles hold great
promise for more sophisticated drug/gene delivery systems to single cells. Outermost
layers can include cell targeting and cell-entry facilitating molecules. The next year
can include intracellular targeting molecules for precise delivery of the nanoparticle
complex inside the cell of interest. Importantly the full nanoparticle system can be
used to prevent any cells from encountering the drug unless that cell is specifically
targeted.
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5.3 Materials and Methods
5.3.1 Materials
The 78 nm Silica particles used as cores were obtained from Nissan Snowtex. The
inner layer of PEI (mol. Wt 10000 gm/mole) was purchased from Polyscience. The
plasmid DNA was produced at UTMB, Galveston, Texas. The outer targeting moieties
N-acetyl-d-galactosamine (GALA) (221.2 gm/mole), poly-l-arginine (14000 gm/mole)
and protamine sulphate (5120 gm/mole) and Lipofectamine 2000 (lipid) were products
of Sigma. The media used for preparation of the nanoparticles were 20 mM Tris buffer
and .5M NaCl salt also products of Sigma. The cells were stained with DAPI (blue,
Molecular Probes,

Inc.)

and

for cell

culture

and

transfection

FBS

and

Penicillin/Streptomycin were also purchased from Sigma.

5.3.2 Fabrication of Nanoparticles
bv LbL
100 pi of 78 nm silica particle solution was taken and 400 pi of PEI (mol. Wt 10,000
gm/mole) at 2mg/ml concentration was added to it, and the mixture was allowed to
self assemble for 15 min. Layer-by-Layer deposition of oppositely charged
polyelectrolyte on the core was observed. [Figure 5.2: Schematic of LbL particles]
The mixture was centrifuged at 7000 rpm for 8 min and supernatant was removed.
Three washes were given after each deposition of layer. Following the PEI layer,
plasmid enhanced green fluorescent protein (DNA) was deposited. Depending on the
charge o f the outer targeting layer N-acetyl-d-galactosamine and lipid monolayer were
deposited on DNA. The layer deposition and washing process was continued till the
nanoparticles o f desired composition were obtained.
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Figure 5.2: Schematic of LbL

5.3.3 C Potential Measurements and
Particle Sizing
Deposition of oppositely charged layers was characterized with the help of C, Potential
measurements [Figure 5.3: Charge measurement of LbL assembly through Zeta].
The measurement o f the sizing of the LbL fabricated nanoparticle was performed by
Particle sizing. These measurements were carried out in Zeta Plus Particle Analyzer
(Brookhaven Instruments Corp., Holtsville, New York)
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Figure 5.3: Charge measurement of LbL assembly through Zeta
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5.3.4 Quartz Crystal Microbalance
The thickness o f the layers in LbL can be organized precisely and in the nanometer
range. This characterization is done with the help of Quartz Crystal Microbalance
(Sanwa Tsusho Co., Ltd., Japan). The resonator is used as the depositing surface and
after each deposition o f the layer the frequency shift is noted. The frequency shift is
proportional to the thickness of layer deposited. Here the deposition of the different
layers is characterized. [Figure 5.4: QCM Characterization of LbL assembly]
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Figure 5.4: QCM Characterization of LbL assembly

5.3.5 Atomic Force Microscopy
Characterization
The nanoparticles assembled through the LbL have different sizes ranging from 126
nm, 210 nm, and 1500 nm. The nanoparticles are constructed from depositing PEI
(10000 gm/mole) layers on silica particles. The diameter of the PEI is .2 nm and the
length o f the polymer is 51 nm approximately. The alternate layer deposited was DNA
of diameter 2nm and length of 2526 nm approximately. The length o f the DNA
molecule are too long, so during the process of the assembly several silica particles in
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the solution attaches to the DNA, thereby increasing the size. Two more monolayers
o f PEI on the DNA and thereafter DNA on PEI were deposited, thus increasing the
size of the nanoparticle. Before addition of the final targeting moieties, the DNA
forms complexes with PEI and condenses on the nanoparticles. Thus, the particles of
higher size ranges are produced. Also, the sample preparation was done in different
media. The nanoparticles with size ranging from 126 nanometer were prepared in DI
water, the 210 nm size nanoparticles were prepared using 20mM of Tris buffer and
.5M NaCl salt whereas the 1500 nm size nanoparticles were prepared with only 20
mM Tris buffer. Figure 5.5 shows smaller particles of 100-nm size range, whereas
Figure 5.6 depicts the size range of 200 nm. In Figure 5.7 it shows the aggregates of
the particles and Figure 5.8 indicates different shapes and size of particles obtained.
Atomic force microscopy images were obtained with a Q-Scope 350 AFM (Quesant
Instrument corporation, USA) operating in tapping mode.

Figure 5.5:100 nm size range nanoparticles characterized by AFM
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Figure 5.6: 300 nm range nanoparticles characterized by AFM

Figure 5.7: Agglomerates of several nanoparticles thereby increasing the size
characterized by AFM
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Figure 5.8: AFM picture indicating different shapes and size of nanoparticles

5.3.6 Cell Culture and Transfections
Cells were incubated at 37 C in 5% CO2 . Huh-7 cell lines were cultured in DMEM
supplemented with 10% FBS and Penicillin/Streptomycin. Cells were transiently
transfected with Lipofectamine2000 (Invitrogen, Inc.) using the manufactures
instructions. Each experiment was done at least in triplicate and positive and negative
controls were present in all experiments.

5.3.7 Confocal Microscopy
Cells were examined with a Zeiss 510 META confocal microscope. Excitation
wavelengths depending on the fluorescent probes used. Appropriate emission
wavelengths were determined and used for each fluorochrome used. Cells were
analyzed with 20, 40, 63, or 100X objectives. A 20X objective was used for imaging
large numbers o f cells for analysis.
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5.3.8 Flow Cytometry
Samples were analyzed by flow cytometry with either a FACScan (Beckton
Dickinson, Inc.) or a home-built, high-speed cell sorter. Briefly, treated cells were
trypsonized to attain a single cell suspension. Then, the cells were fixed,
permeablized, and stained as described above. These cells were then filtered with a
70pm mesh cell strainer (Falcon) and analyzed by flow cytometry. GFP samples were
excited using an Argon ion laser tuned to 488nm and detected after 488nm band reject
and 530nm band pass optical filters (Omega Optical, Inc.).

5.4 Results
5.4.1 Effect of Size and Outer
Coating on Cells
The nanoparticles were constructed using the surface charge chemistry of the
components. The size of this vector can be controlled within the specific range this
gives advantage in making the particles through this approach. Changing the core or
the monolayer chemistry o f the targeting moieties, the whole architecture of the
nanoparticles can be designed. Several experiments were performed with one or more
layers of DNA but it was concluded that one layer of DNA is efficient for transfection.
LbL targeting nanoparticles were constructed and delivered to the cell. The
nanoparticle had one o f the layers as DNA and was constructed in size groups of 126,
210, and 1500nm all coated with GALA as targeting moiety. These nanoparticles were
incubated with Huh-7 cells for 24 hours. After 24 hours the cells were counterstained
with DAPI. The cells were then viewed, counted, and photographed with a confocal
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microscope. Figure 5.9 represents the transfection efficiency derived from cell counts
for each of the three sizes and treatment groups. Figure 5.10 represents the transfection
efficiency derived from cell counts for each of the three size treatment groups from
lipid outer coating. The same procedure was followed for each of the groups. Our
idealized nanoparticles even at bigger size would be one, which can be endocytosed
but not just penetrate. The results for the transfection concluded that lipid particles
showed higher transfection rate as much as 22% for 126 nm size group. The
transfection increased as the volume is increased but for the 210 nm and 1500 nm
nanoparticle size group the transfection rate decreased tremendously to nearly 2%.
Whereas for the GALA coated nanoparticles even for the size range 126 nm the
transfection rate was low as compared to lipid-coated nanoparticle to about 10%.
Further increasing the size group at 210 nm the transfection rate remains constant to
10 %. For higher size nanoparticle it is a known fact that there is increase in apoptotic
nuclei, which is supported by our results. The difference in the results for GALA and
lipid nanoparticles indicates that at even higher size for GALA the particles are
endocytosed due to interaction with asialoglycoprotein receptor but not for lipid
nanoparticles which might be just penetrating.
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From the table 5.1 it can be seen that various other architectural nanoparticles were
constructed. In the table the construction of different particles is shown and different
conditions of their fabrication used Nanoparticle of size 621nm with outer coating as
Polygalcatosamine,

Nanoparticle

of

size

415nm

with

outer

coating

as

Polyethyleneimene, Nanoparticle of size 340nm with outer coating as Polyarginine
and Nanoparticle o f size 185nm with outer coating as Protamine were prepared for
DNA delivery. These particles were constructed as it had been reported earlier that
these molecules have been used for similar DNA delivery research. It was seen that
the uptake of particles was almost 0 % while protamine, polygala, PEI and other
targeting moieties were used.. These facts determine that even particles with size less
than 200 nanometer were constructed for DNA delivery with outer coating of
Protamine but failed to show any transfections rate which was seen earlier for
galactosamine coated nanoparticles. Thus layer-by-layer renders the ability to choose
specific cell type with receptor binding affinity and target individually with specific
outer targeting strategy.
This research has following challenges to overcome:
•

Cells are widely known to only allow particles within a particular size range
upto 300 nm, to pass the outer membrane. The nuclear membrane is even more
tightly guarded, only allowing specific molecules to pass into the nuclear
compartment. Passing through these barriers is paramount for the success of
DNA delivery. The size of the particles delivered is therefore critical for the
success o f nanoparticle mediated gene delivery. The major size determinant for
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the nanoparticles is the nature of the core particle, onto which the coats are
layered as well as the coating materials used.
•

The DNA used for this study was of approximate length 2526nm and the silica
cores used were of the size range 78nm, hence the particles size distribution,
which was characterized, with the help of AFM and Zeta Potential indicated
very unclear pattern of fabricated nanoparticles. DNA being so long molecule
would eventually have more than 1 core particles around it due to the charge
potential, as the silica were coated with positively charged PEI. If the DNA
length would be reduced and thereby containing the same gene code for
protein expression in the targeted cell type, possibility of constructing such
ideals nanoparticles would be evident.

This work was a part of NASA project “Nanoparticles for DNA delivery”.
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Table 5.1: Different customized nanoparticles architecture
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CHAPTER 6

NANOASSEMBLY OF BIODEGRADABLE
MICROCAPSULES FOR
DNA ENCASING

6.1 Introduction
In a previous chapter, we described formation of vector (DNA Delivery System) based
on nanoparticle construction. In this chapter we have encapsulated DNA in a micro
container with biodegradable coating for DNA delivery. The development of layer-bylayer (LbL) self-assembly technology [3, 47, 108, 109] promises a solution to many
problems of modem biotechnology. Encapsulation of DNA molecules in micro- and
nanovolume is an important goal. Although considerable progress was made in gene
therapy and DNA vaccine technology, a problem of DNA degradation upon delivery
still remains.[110, 111] It is important to develop a carrier system that can penetrate
cell shell and protect plasmid DNA from degradation. Depot and delivery systems
such as polymer microparticles prepared using emulsion method, solvent-diffusion
nanospheres, and liposome provided an essential progress in DNA delivery. [112-114]
However,

not
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high enough efficiency of encapsulation and needs to engineer the structure and
properties of protective shell on nanometer scale provide an avenue for further efforts
in this direction. In this work we propose a new “vehicle” for DNA delivery based on
microcapsules with 40 nm thick molecularly organized biocompatible shell.
Polyelectrolyte capsules, first reported in [74], are based on application of LbL
assembly of nanometer thick polymeric films with controlled composition and
properties onto the surface of decomposable tiny cores. A variety of materials
(synthetic and natural polyelectrolytes, proteins, multivalent ions, inorganic and
organic nanoparticles, lipids) were used as components of the capsule shell providing
versatile properties. [68, 74, 115, 116] Macromolecules can be introduced inside the
capsules by two ways: first, using encapsulated material as template core, and second,
loading macromolecules into preformed polyelectrolyte shell. Adjusting shell
permeability by changing a solvent (water-alcohol-acetone), ionic strength or pH
allows controlling release o f encapsulated compound. [79, 80]

6.2 Microencapsulating DNA and Characterizing
In this study, a novel process of microencapsulating DNA in biocompatible poly[/3glucuronic

acid-(l-> 3)-N-acetyl-/3-galactosamine-6-sulfate-(l-* 4)]

(known

as

chondroitin sulfate, Sigma) (PG) / poly(-L-arginine) (PA) capsules of 4 pm diameter
was developed. DNA molecules were deposited by controlled precipitation of
DNA/Sperimidine (Sp) complex onto a surface of template microparticles followed by
LbL assembly of PA and PG protective biocompatible shell. Large 4 pm capsules were
taken as model to develop DNA encapsulation procedure and understand DNA
behavior in capsule volume.
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MnCC>3 particles of 4 pm diameter (from PlasmaChem Gmbh) were taken as template
cores. 0.5 mg/mL MnCCh particle suspension (30 ml) was mixed with 1 mL of 1.5
mg/mL DNA solution (highly-polymerized DNA sodium salt from Calf Thymus,
Sigma). Precipitation of DNA/Sp complex on template particles was made adding
dropwise 2 mL of 1 mg/mL sperimidine solution into stirred MnC0 3 /DNA solution
(Fig. 6.1a,b). Further alternated LbL assembly of biocompatible PA/PG shell was
carried out with 1 mg/mL PA or PG solutions (Fig. 6.1b,c). After each deposition step,
microparticles were washed out 3 times. A layer-by-layer assembly of polyelectrolyte
layers was monitored by electrophoretic mobility measurements (ZetaPlus Zeta
Potential Analyzer, Brookhaven Instr. Corp). For each sample, 4 PA/PG bilayers were
deposited with PA as the last monolayer and surface potential of the capsule regularly
changes from +40 mV for PA to -35 mV for PG, indicating formation of the planned
wall composition. 5 nm assembly step for PA/PG was found from parallel PA/PG
assembly on QCM electrode (Quartz Crystal Microbalance, USI-System, Japan).
Therefore, a total capsule wall thickness was 40 nm. PA capsule outermost was chosen
because of its potential to increase translocation activity through the cell
membranes.[117, 118] The mass of capsules were measured in another QCM
experiment when 8 pL o f empty or loaded capsule solution of known concentration
was dried on QCM electrode, and their weight was measured.
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DNA

Figure 6.1: Schematic illustration of the DNA encapsulation process. A-B: controlled
precipitation of DNA/Sperimidine (Sp) complex on the surface of template particles;
B-C: LbL assembly of protective biocompatible shell; C-D: template dissolution; D-E
DNA/Sp complex dissolution

At the final step, MnCC>3 template particles were dissolved in deaerated 0.01 M HC1.
As a result, biocompatible PA/PG capsules containing DNA/Sp complex were
obtained. After removal of the core, the capsules were studied with confocal
fluorescence microscopy (Leica DM IRE2 Confocal Fluorescence Microscope).
Figure. 6.2a illustrates a typical fluorescence image of (DNA/Sp)PA/PG capsules
immediately after dissolution of template. Fluorescence signal is caused by presence of
Rhodamine-labeled DNA [115, 119] in the capsule interior. The cross-section profile
o f fluorescence intensity along the capsule diameter gives the DNA distribution. There
are two peaks demonstrating that DNA was confined initially to the inner capsule
walls. Then these capsules were treated with 0.1 M HC1 for 10 min.
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Figure 6.2. Fluorescence comocai microscopy images oi tne DNA-containing
capsules composed of 4 PA/PG bilayers just after decomposition of template
core (A) and after dissolution of the inner DNA/Sp complex (B). Areas
under the curves are similar. The inset demonstrates the fluorescence
profile for both cases

Such treatment leads to the decomposition of DNA/Sp complex formed in aqueous
solution at neutral pH. [116] Thus, low-molecular weight sperimidine was released
and removed from the capsule interior. Now, the capsule is filled with freely floating
DNA molecules, a result proved by fluorescence signal from the whole capsule
volume (Fig. 6.2b). The fluorescent signal is distributed evenly over the capsule
interior.
During optimization o f DNA adsorption we found that 100 % of DNA could be
deposited on the template surface from the water solution as DNA/Sp complex.
Judging upon precipitation yield, quantity of the capsules in solution (~108), and mass
o f DNA captured in one capsule (12 pg as measured using Quartz Crystal
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Microbalance), one can estimate the average concentration of DNA in the capsule
volume. The average concentration of DNA that is to be encapsulated through L-b-L
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Figure 6.3. Circular dichroism spectra of initial DNA (1);
DNA captured in capsule volume (2); DNA in 0.1 M HC1 (3).
via DNA/Sp complex 0.4 mg per 1 ml of capsule volume. Due to the helical structure
o f double-stranded DNA, its circular dichroism (CD) spectrum has a strong signal in
230-350 nm range. [120-122] In Figure 6.3 the CD-spectra of initial DNA, DNA
treated with 0.1 M HC1, and DNA captured in capsule volume are compared (Jasco J810 spectropolarimeter). The spectrum of initial DNA in water solution is typical of
the double helix B-conformation of DNA. Adding HC1 to DNA solution results in
disappearing of negative band at 230-260 nm caused by denaturation of double
stranded DNA. [120-122] However, after decomposition of DNA/Sp complex CD
spectrum o f DNA captured inside PA/PG microcapsules reveals minor changes as
compared to initial DNA. Such insignificant changes in diachronic bands for DNA
captured inside in all likelihood evidence primary preservation of double helix
structure. Apparently, sperimidine and polyarginine partially compensate in capsule
volume negative effect o f low pH forming pH gradient across the capsule shell which
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was previously observed for polyelectrolyte capsules containing polyamines inside.
[123-125]

6.3 Conclusion
In conclusion, we developed a versatile approach for DNA encapsulation inside
protective biocompatible polyelectrolyte microshell retaining natural double-helix
structure of DNA molecules captured inside. Currently, this technique is employed for
targeted delivery of plasmid DNA in living cell using capsules of a smaller diameter
(300 nm). We have demonstrated the capability to encase DNA in microcontatiners
thereby retaining its activity. As following from the previous chapter for better gene
delivery one has to make these capsules/nanoparticles smaller in size and it will be the
next big challenge.
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CHAPTER 7

CONCLUSION

7.1 Enzyme Encapsulation
Thin wall microcapsules were formed via a layer-by-layer self-assembly by eight to ten
steps of alternate adsorption of oppositely charged poly(styrenesulfonate) and
poly(allylamine) on microcores. After the core dissolution, empty polymeric shells
with 20-25 nm thick walls were obtained. These microcapsules were loaded with
myoglobin, hemoglobin and glucose oxidase by opening capsule pores at low pH and
closing them at higher pH. At the concentration of the loading proteins o f 1 mg/mL,
they result in ca 30 mg/mL protein concentration. The native structure of the enzyme
was not affected due to different treatments and this will open new ways for the use of
the microcontainers as reactors, for Bio assay, sensoric devices and other complex
application.

7.2 Nanoparticles DNA Delivery Systems
DNA, used as one of the layers in the nanoparticle architecture, was delivered to the cell
indicated by the fluorescence. The size parameter was studied for the targeting of the cell
type and gene delivery systems. It was shown that for successful transcription the
nanoparticle should be less than 300 nm in size and such particles can be easily
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endocytosed by cells. This research will enhance the use of DNA as one of the layers in
constructing nanoparticles and new designed outer coatings can be further used to target a
specific cell type.

7.3 Microencapsulation of DNA as New Gene Vector
In presented work we have made an attempt to elaborate detailed procedure for DNA
encapsulation

inside

biocompatible

poly(-L-arginine)/poly(galactosamine)

polyelectrolyte capsules of 4 micro meter diameter. This procedure can be further
employed for preparation of nanosized DNA-containing polyelectrolyte microcontainers
for target DNA delivery in cell. It was shown that the encapsulated DNA preserves its
initial native structure. This system would be a model systems and a challenge for
fabricating DNA delivery vector that can be easily endocytosed and thereby curing many
diseases.
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